J2021 HCPCS code: Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
J2021 is the HCPCS Level II code for injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 6 per day on outpatient hospital claims.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-01-01 |
| Last action effective | 2024-07-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 6 | Prescribing Information |
| practitioner claims | 6 | Prescribing Information |
What changed for J2021
- 2023-01-01: J2021 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2021?
J2021 is the HCPCS Level II code for injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg. Short descriptor: "Inj, linezolid (hospira)".
Does Medicare cover J2021?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2021 can be billed per day?
6 on outpatient hospital claims; 6 on practitioner claims (NCCI medically unlikely edits).
Related J20 codes
- J2001 — Injection, lidocaine hcl for intravenous infusion, 10 mg
- J2002 — Injection, lidocaine hcl in 5% dextrose, 1 mg
- J2003 — Injection, lidocaine hydrochloride, 1 mg
- J2004 — Injection, lidocaine hcl with epinephrine, 1 mg
- J2010 — Injection, lincomycin hcl, up to 300 mg
- J2020 — Injection, linezolid, 200 mg
- J2060 — Injection, lorazepam, 2 mg
- J2062 — Loxapine for inhalation, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2021
- Watch J2021 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2021
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.